BioVentrix, Inc., a privately held medical device company developing minimally invasive therapies to directly treat the dilated left ventricle and reverse the left ventricular remodeling process in patients with congestive heart failure, today announced the completion of $48.5 million Series A round financing.
Who to call at BioVentrix, and when
A new round usually means BioVentrix is about to hire and buy. The teams that reach out first get the meeting.
An alert the day BioVentrix raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at BioVentrix, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioVentrix. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
BioVentrix
Location
120 FORBES BLVD.
Mansfield, Massachusetts, United States
About
BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA. Our mission is to improve and expand the treatment available for congestive heart failure (CHF) caused by ischemic cardiomyopathy, through the development of less invasive, catheter-based approaches.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioVentrix raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
MansfieldOtherMedical